Top compounds associated with response to EIF2B3


Feature Type Standardized
Nominal ANOVA
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.054 0.1
mRNA niclosamide CTRPv2 pan-cancer AAC 0.058 0.1
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.05 0.1
mRNA Sunitinib CTRPv2 pan-cancer AAC -0.055 0.1
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.053 0.1
mRNA myriocin CTRPv2 pan-cancer AAC -0.13 0.1
mRNA tivantinib CTRPv2 pan-cancer AAC 0.071 0.1
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.1
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC -0.059 0.1
mRNA Tipifarnib FIMM pan-cancer AAC -0.21 0.1
Download CSV